An estrogen receptor antagonist, Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. It is administered intramuscularly. Reference standards of Fulvestrant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => (7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,6,6,7,7,7-nonafluoroheptyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol [catalogue_number] => PA 06 54540 [category_ids] => ,92,78,70,82,89,88,80, [chemical_name] => [weight] => 706.79 [form] => C34H47F9O3S [cas] => NA [pslug] => 7r-8r-9s-13s-14s-17s-13-methyl-7-9-4-4-5-5-6-6-7-7-7-nonafluoroheptyl-sulfinyl-nonyl-7-8-9-11-12-13-14-15-16-17-decahydro-6h-cyclopenta-a-phenanthrene-3-17-diol-pa0654540 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 06 54540
CAS :
Molecular Formula : C34H47F9O3S
Molecular Weight : 706.79
stdClass Object ( [pname] => Fulvestrant System Suitability Mixture [catalogue_number] => PA 06 0541008 [category_ids] => ,80,71,76,75,93,78,70,82, [chemical_name] => [weight] => 606.78 [form] => C32H47F5O3S [cas] => NA [pslug] => fulvestrant-system-suitability-mixture-pa060541008 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 06 0541008
Molecular Formula : C32H47F5O3S
Molecular Weight : 606.78
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
